Cited 0 times in Scipus Cited Count

De novo Cancer in Renal Transplant Recipients

Other Title
신장이식후 발생한 악성 종양
김, 명수 | 정, 구영 | 이, 강영 | 오, 창권  | 김, 순일 | 김, 유선 | 박, 기일
Journal of the Korean Surgical Society, 50(6). : 1021-1027, 1996
Journal Title
Journal of the Korean Surgical Society
The increased risk and different behavior of de novo cancer in immunosuppressed transplant recipients is widely is widely accepted. Also, a different pattern of cancer incidence is observed based on the type of immunosuppressive agents. But the incidence and the predominant type of cancer in Asian countries is different from that of Western countries. Herein, we report on the incidence and pattern of de novo cancer in renal transplant recipients at Yonsei University Hospital. We reviewed 1,313 patients who underwent kidney transplantation at our hospital from April, 1979 through July. 1995. One hundred and sixteen patients received azathioprine(AZA) based immunosuppression and 1197 patients received cyclosporin(CyA) based immunosuppression. All cancers were confirmed by pathological study.
The results were as follows;
1) The overall cancer incidence was 1.52%(20 of 1313 patients) but the cancer incidence increased as follow up time increased. Cancer incidence in recipients whose follow up duration was less than 3 years it was 0.27%, between 3 and 6 years was 1.44% and for more than 6 years was 2.95%(p=0.015).
2) There was no difference in cancer incidence according to the type of immunosuppressive agent. There was no relationship between the episode of early rejection(onset within 1 month) and cancer incidence(1.68% vs. 1.37%, p=0.2468).
3) The mean interval between renal transplantation and cancer diagnosis was 45.6 months. The mean age of cancer diagnosis was 44.8% years.
4) The sites of cancer were cervix(n=6, 30%), GI(n=4, 20%), lung(n=3, 15%), thyroid(n=3, 15%), skin(n=1, 5%), Kaposi's sarcoma(n=1, 5%), lymphoma(n=1, 5%) and plasmocytoma of gingiva(n=1, 5%). The incidence of skin cancer and lymphoma was lower than that in Western countries.
5) De novo cancer such as early stage stomach cancer, cervical cancer, thyroid cancer and skin cancer were treated with only surgical excision without any modulation of immunosuppressive agents with the exception of Kaposi's sarcoma and lymphoma.
6) Cancer related mortality was 20%(4 of 20 patients) and all of these patients had advanced-stage cancer at the time of diagnosis. Therefore, early detection of de novo cancer during the follow up period is recommended to decrease the cancer induced mortality in transplant recipients.
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Ajou Authors
오, 창권
Files in This Item:
There are no files associated with this item.


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.